HVIA
TEVA icon

Hudson Valley Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Hudson Valley Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,886
Closed -$346K – 150
2016
Q2 		$346K Sell
6,886
-400
-5% -$21.3K 0.11% 116
2016
Q1 		$390K Sell
7,286
-150
-2% -$8.8K 0.13% 113
2015
Q4 		$488K Sell
7,436
-1,300
-15% -$80.3K 0.15% 112
2015
Q3 		$493K Sell
8,736
-700
-7% -$45.4K 0.16% 107
2015
Q2 		$558K Buy
9,436
+2,400
+34% +$148K 0.17% 94
2015
Q1 		$438K Buy
7,036
+650
+10% +$37.8K 0.15% 97
2014
Q4 		$367K Buy
6,386
+50
+0.8% +$2.79K 0.15% 95
2014
Q3 		$341K Hold
6,336
– – 0.14% 96
2014
Q2 		$332K Sell
6,336
-1,250
-16% -$63.9K 0.14% 95
2014
Q1 		$401K Buy
7,586
+200
+3% +$9.24K 0.17% 91
2013
Q4 		$296K Sell
7,386
-1,600
-18% -$63K 0.13% 103
2013
Q3 		$339K Sell
8,986
-1,550
-15% -$60.5K 0.16% 95
2013
Q2 		$413K Buy
+10,536
New +$410K 0.2% 81

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hudson Valley Investment Advisors's TEVA Position: Q3 2016 in Review

Hudson Valley Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 6,886 shares — an estimated $346K sold.

Hudson Valley Investment Advisors first reported a position in TEVA in Q2 2013 and held it in 13 quarters. The position peaked at $558K in Q2 2015. 796 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Hudson Valley Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Hudson Valley Investment Advisors sold 6,886 Teva Pharmaceuticals shares in Q3 2016, an estimated $346K.
  • Hudson Valley Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Hudson Valley Investment Advisors's Teva Pharmaceuticals position peaked at $558K in Q2 2015.
  • 796 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Hudson Valley Investment Advisors's 13F filing for Q3 2016, filed 11 Oct 2016.